[HLA-SD-antigens in cervix cancer and recurrent herpes genitalis patients (author's transl)].
The frequency of 36 HLA-SD antigens were investigated in 42 patients with cervix cancer, 36 female patients with recurrent Herpes genitalis and 450 healthy controls. The only significant difference between the 3 groups was an increase in the frequency of BW 15 in the cervix cancer patients. The patients with recurrent Herpes genitalis--who were sero-epidemiologically determined to have a higher risk of developing a cervix carcinoma-showed no significant difference in their HLA-SD antigen frequencies in comparison with the controls and the cervix carcinoma patients.